Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products ...

As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage’s growth and digital transformationSALT LAKE CITY, Jan. 16 ...

Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks ...

(RTTNews) - LifeVantage Corp. (LFVN), a health and wellness company, on Wednesday reported a rise in preliminary revenue for the second quarter, helped by strong sales and business momentum.

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

SALT LAKE CITY, Dec. 03, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

As of December 23, 2024, the average one-year price target for LifeVantage is $26.52/share. The forecasts range from a low of $26.26 to a high of $27.30. The average price target represents an ...